|
1
|
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
|
Anal Biochem
|
1999
|
1.34
|
|
2
|
Induced sputum eicosanoid concentrations in asthma.
|
Am J Respir Crit Care Med
|
1999
|
1.24
|
|
3
|
Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells.
|
Inflammation
|
2001
|
1.24
|
|
4
|
Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
|
Am J Respir Crit Care Med
|
2000
|
1.15
|
|
5
|
Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice.
|
Am J Respir Crit Care Med
|
2000
|
1.12
|
|
6
|
Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.
|
Am J Respir Crit Care Med
|
1996
|
1.09
|
|
7
|
Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin.
|
Am Rev Respir Dis
|
1990
|
1.08
|
|
8
|
Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge.
|
Am J Respir Crit Care Med
|
1994
|
1.05
|
|
9
|
Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability.
|
Thromb Haemost
|
1985
|
0.92
|
|
10
|
Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid.
|
J Allergy Clin Immunol
|
2001
|
0.89
|
|
11
|
Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics.
|
Am J Respir Crit Care Med
|
2000
|
0.88
|
|
12
|
Cyclosporin for steroid-dependent asthma.
|
Allergy
|
1991
|
0.87
|
|
13
|
Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism.
|
J Immunol
|
1993
|
0.86
|
|
14
|
Glutathione S-transferase P1 Ile105Val polymorphism modulates allergen-induced airway inflammation in human atopic asthmatics in vivo.
|
Clin Exp Allergy
|
2013
|
0.81
|
|
15
|
Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism.
|
Am J Respir Crit Care Med
|
1998
|
0.80
|
|
16
|
[Lipid peroxides and antioxidants in the plasma of healthy persons and in patients with arteriosclerosis].
|
Pol Arch Med Wewn
|
1986
|
0.78
|
|
17
|
Glutathione S-transferase M1 modulates allergen-induced NF-κB activation in asthmatic airway epithelium.
|
Allergy
|
2014
|
0.78
|
|
18
|
Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor.
|
Prostaglandins
|
1995
|
0.78
|
|
19
|
Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients.
|
Clin Exp Allergy
|
1990
|
0.78
|
|
20
|
Cyclosporin for a severe case of aspirin-induced asthma.
|
Eur Respir J
|
1991
|
0.76
|
|
21
|
Choline magnesium trisalicylate in patients with aspirin-induced asthma.
|
Eur Respir J
|
1990
|
0.76
|
|
22
|
Urinary mediators and asthma.
|
Clin Exp Allergy
|
1998
|
0.75
|
|
23
|
[Effect of vitamin E on the changes in plasma lipid peroxides and platelet aggregation in patients with hyperlipoproteinemia].
|
Pol Arch Med Wewn
|
1986
|
0.75
|
|
24
|
Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.
|
J Allergy Clin Immunol
|
1987
|
0.75
|
|
25
|
[Leukotrienes and bronchial asthma].
|
Pol Arch Med Wewn
|
1991
|
0.75
|
|
26
|
[QT interval prolongation in the ECG as a predictor of sudden death in myocardial infarction].
|
Kardiol Pol
|
1982
|
0.75
|
|
27
|
[Blood platelets and myocardial infarction].
|
Pol Tyg Lek
|
1984
|
0.75
|
|
28
|
[Free radicals and antioxidants. Role of lipid peroxides in the development of arteriosclerosis].
|
Pol Tyg Lek
|
1986
|
0.75
|
|
29
|
[Effect of troxerutin on bronchial spasm induced by inhalation of a specific allergen and on the neutrophil activity in patients with atopic bronchial asthma].
|
Pol Tyg Lek
|
1987
|
0.75
|
|
30
|
[The role of respiratory tract infections in the pathogenesis of bronchial asthma].
|
Pol Tyg Lek
|
1989
|
0.75
|
|
31
|
[Polyunsaturated fatty acids in the prevention of arteriosclerosis].
|
Pol Tyg Lek
|
1984
|
0.75
|
|
32
|
[Treatment of ischemic ulcers of the extremities with intravenous intermittent infusions of prostacycline].
|
Pol Tyg Lek
|
1986
|
0.75
|
|
33
|
Prostaglandins in Ascaris antigen.
|
J Allergy Clin Immunol
|
1988
|
0.75
|
|
34
|
[Pollen fallout and symptoms of hay fever].
|
Pol Tyg Lek
|
1985
|
0.75
|
|
35
|
Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.
|
Adv Prostaglandin Thromboxane Leukot Res
|
1987
|
0.75
|